FPIs pull out Rs 22,400 crore so far in November, selling pressure continues
Foreign Portfolio Investors (FPIs) have maintained their bearish stance on Indian markets in November, extending their massive selloff from October, ...
Tag: Pull
FDA to pull common but ineffective cold medicine from market
The Food and Drug Administration announced Wednesday that it would seek to pull a widely used ingredient in cough and ...
FPIs turn net sellers; pull out Rs 21,201 crore from equities in Aug so far
Foreign investors continued their relentless selling in the Indian equity markets in August, offloading shares worth Rs 21,201 crore due ...
Ethereum Price Wavers As Institutional Investors Pull $60.7 Million In One Week | Bitcoinist.com
Crypto investment products tracking Ethereum and others registered another week of outflows last week, albeit at a lesser amount, to ...
Dollar Tree failed to pull lead-contaminated applesauce for months, FDA says
Applesauce packets recalled due to levels of lead Applesauce packets recalled due to levels of lead 00:37 Applesauce pouches contaminated ...
Walmart and Target earnings pull back the curtain on an America struggling with high inflation
Economists have been looking for cracks in U.S. consumer spending for years now amid persistent inflation and higher interest rates, ...
Lyft shares pull way back after CFO corrects major earnings release error
Air travelers walk toward a Lyft pickup area at Los Angeles International Airport in Los Angeles on Aug. 20, 2020.Mario ...
Binance users pull over $1 billion from the exchange after CEO leaves, pleads guilty
Binance's Co-founder & CEO Changpeng Zhao speaks during the 2022 Web Summit in Lisbon, Portugal, on November 1, 2022. Ben Mcshane ...
CVS to pull certain cold medicines containing decongestant phenylephrine from store shelves
Cold and flu medicine including NyQuil sit on a store shelf in Miami on Sept. 12, 2023.Joe Raedle | Getty ...
Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas
Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson's consumer-health business, speaks during an interview to celebrate its IPO ...
